Taining Golden Lake Comprehensive Chronic Disease Management Initiative

Study acronym: TAIGOLD-CDM
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Aug 1, 2027 → Aug 1, 2029
See other at-risk trials from First Affiliated Hospital of Fujian Medical University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 1, 2027 to Aug 1, 2029
    • Study completion pushed from Jul 1, 2028 to Jul 1, 2030
    • Eligibility criteria expanded, about 10 words
    • Publications: details revised at 12 of 12 entries
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This study aims to establish the first county-level, population-based prospective cohort in Taining County, Fujian Province, China. The cohort will include at least 20,000 residents aged 18 years or older. The project will systematically collect questionnaires, physical measurements, laboratory tests, imaging data, and biological samples to build a multi-dimensional health database and biobank. Through 3-year follow-up, the study seeks to reveal the epidemiological patterns and risk factors of chronic diseases, characterize the natural course of multimorbidity and aging syndromes, and develop a comprehensive chronic disease management model suitable for rural and mountainous regions.
Trial Details
NCT Number NCT07308314
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions
(from sponsor)		 Chronic Disease, Chronic Disease Management, Hypertension, Diabetes Mellitus, Dyslipidemias, Frailty, Sarcopenia
Related terms Cardiovascular Diseases, Chronic Disease, Diabetes Mellitus, Dyslipidemias, Frailty, Hypertension, Sarcopenia
Enrollment 20,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov